Tanner Wilson alias Dr. Lab Lord

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Bioidentical Hormone Replacement Therapy (BHRT).

Bioidentical Hormone Replacement Therapy (BHRT)

Supports

High-quality evidence supports the use of bioidentical hormones (particularly FDA‑approved estradiol and progesterone) for standard indications such as menopausal symptom relief, premature ovarian insufficiency, and related conditions, including RCTs and systematic reviews.^{[7][9][5][19][20][21][22]} Several reviews and expert opinions describe bioidentical hormone therapy (including transdermal estradiol and micronized progesterone) as effective and with an acceptable safety profile when prescribed and monitored within conventional medical practice.^{[9][18][19][20][21][22]} However, this supporting evidence pertains to hormone therapy itself, not to chiropractic adjustment or chiropractic‑specific management of BHRT; the index guideline papers provided deal with hypertension, nutrition, headache, transfusion, etc., and do not address BHRT or chiropractic scope of practice.

Contradicts

Mainstream endocrine and menopause guidelines emphasize that bioidentical hormones should be prescribed and monitored within regulated medical frameworks, and specifically caution against unregulated compounded bioidentical hormone therapy (cBHT), citing lack of long‑term safety data and documented cases of harm such as virilization from pellet therapy.^{[7][11][17][20][21]} There is no high‑quality evidence (RCTs, systematic reviews, or major guidelines) showing that chiropractic spinal manipulation itself treats hormonal deficiency or is an evidence‑based primary modality for BHRT; available data and guidelines focus on pharmacologic hormone prescribing, not chiropractic interventions.^{[7][9][19][20][21][22]} Regulatory scope‑of‑practice standards for chiropractors in many jurisdictions define chiropractic practice around assessment and treatment of spine and neuromusculoskeletal conditions, not prescribing systemic hormone therapies, which implies that chiropractor‑led BHRT is outside or at least at the edge of typical regulated practice.^[13] The provided index guideline papers on hypertension, nutrition, headache, parenteral nutrition, blood transfusion, and colchicine do not support or recommend BHRT or chiropractic involvement in hormone prescribing, underscoring the absence of guideline‑level endorsement of chiropractic BHRT.

Mainstream view

The mainstream medical position is that bioidentical hormone therapy (especially FDA‑approved estradiol and micronized progesterone) can be appropriate and effective for clearly defined indications (e.g., bothersome menopausal symptoms, premature ovarian insufficiency), when prescribed, dosed, and monitored by clinicians trained in endocrine and gynecologic care, following evidence‑based menopause and endocrine guidelines.^{[7][9][19][20][21][22]} Major endocrine societies and expert groups support regulated, approved bioidentical formulations but advise against routine use of custom‑compounded BHRT because of variable dosing, purity concerns, and insufficient long‑term safety data.^{[7][11][5][17][20][21]} Chiropractic care is generally recognized as a musculoskeletal and spine‑focused discipline; mainstream guidelines do not endorse chiropractors as primary prescribers or managers of systemic hormone replacement therapy, and there is no guideline‑level evidence that chiropractic adjustments constitute an evidence‑based treatment for hormonal deficiency.^{[13][7][9][20][21]} Thus, while BHRT itself can be evidence‑based in appropriate contexts, the specific claim that chiropractor treatment of BHRT is an established, guideline‑supported medical practice is not aligned with mainstream medical standards.

In their own wordsView sourceArchived copy

“Bioidentical Hormone Replacement Therapy (BHRT)”

Rule: K.S.A. 65-2871(a)

See every doc bro who says they can treat or advise on Hormone imbalance and replacement

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Prescribing and managing Bioidentical Hormone Replacement Therapy (BHRT), a prescription drug protocol..

Prescribing and managing Bioidentical Hormone Replacement Therapy (BHRT), a prescription drug protocol.

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Bioidentical Hormone Replacement Therapy (BHRT)”

Rule: K.S.A. 65-2871(a)

See every doc bro who says they can treat or advise on Hormone imbalance and replacement

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Hormonal imbalances.

Hormonal imbalances

Supports

High-quality evidence directly showing that chiropractic treatment corrects clinically significant hormonal imbalances is essentially absent. A systematic review of spinal manipulative therapy (SMT) and immune outcomes found only limited preliminary data that SMT may be associated with short‑term changes in immunological and endocrine biomarkers (such as cortisol), but explicitly stated that the clinical relevance of these biomarker changes is unknown and that no clinical evidence supports efficacy for immune outcomes.^[9] Some experimental and small RCT studies outside the indexed list report short-term changes in stress hormones (e.g., cortisol, neuropeptides) after spinal manipulation, suggesting that SMT can acutely influence the neuroendocrine system, but these are lab/biomarker outcomes, not treatment of defined endocrine diseases. Major endocrine guidelines (e.g., Endocrine Society clinical practice guidelines) outline pharmacologic therapy, lifestyle interventions, and occasionally surgery for hormonal disorders, and do not list chiropractic care as a recommended treatment modality.^[13][15]

Contradicts

The available evidence significantly contradicts the strong claim that chiropractic care is an effective treatment for hormonal imbalances as understood in endocrinology. The systematic review of SMT and infectious disease/immune outcomes concluded that there is no clinical evidence that SMT prevents disease or improves immune function, and that short‑term endocrine biomarker changes have unknown clinical relevance.^[9] This finding, along with other reviews summarizing neuroimmunoendocrine effects of spinal manipulation, indicates that observed hormonal changes are small, short-lived, and not linked to correction of disorders such as thyroid disease, diabetes, PCOS, menopause-related hormonal imbalance, or adrenal insufficiency. High-quality management guidelines for endocrine-related conditions (e.g., hypertension guidelines for neurohormonal regulation, nutrition guidelines in chronic disease) rely on medications, diet, and other evidence-based therapies, and do not mention chiropractic as a treatment.^[0][1][2] Overall, the evidence base for chiropractic as a treatment for hormonal imbalance is weak, mixed, and lacks disease-level outcomes.

Mainstream view

The mainstream medical and scientific position is that chiropractic care is primarily an evidence-based treatment for certain musculoskeletal conditions (such as low back pain), and not an established therapy for endocrine or hormonal disorders. Major endocrine societies and guideline groups do not recommend chiropractic as a treatment for hypertension, thyroid disease, diabetes, PCOS, menopausal symptoms, or other hormonal imbalances, instead emphasizing pharmacologic management, lifestyle modification (diet, exercise, weight loss), and other validated interventions.^{[0][1][2][13][15]} While spinal manipulation may cause short-term changes in stress-related hormones or neuropeptides, these effects are considered experimental, of uncertain magnitude and duration, and not sufficient to constitute treatment of endocrine disease. Mainstream clinicians may view claims that chiropractic can "treat hormonal imbalances" as unproven, potentially misleading, and not supported by high-quality randomized trials, meta-analyses, or guidelines.

In their own wordsView sourceArchived copy

“struggling with hormonal imbalances”

Rule: K.S.A. 65-2871(a)

See every doc bro who says they can treat or advise on Hormone imbalance and replacement

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Functional Medicine.

Functional Medicine

Supports

There is moderate-quality evidence that chiropractic spinal manipulative therapy is about as effective as other recommended therapies (such as standard medical care and physical therapy) for short‑term pain relief and small improvements in function in adults with chronic low back pain.^[12][14] Some randomized controlled trials show clinically meaningful reductions in pain and disability with structured courses of chiropractic spinal manipulation (around 12 sessions over 6 weeks) in chronic non‑specific low back pain, with benefits sustained up to 52 weeks.^{[2][7][11][12][14]} A Cochrane review and other systematic reviews indicate that for acute and subacute low back pain, combined chiropractic interventions can slightly improve pain and disability in the short and medium term compared with other treatments, though long‑term differences are minimal.^{[8][12][14][16]} Overall, high‑quality evidence supports chiropractic care as a reasonable option for musculoskeletal spinal pain (especially low back pain), broadly comparable to other conservative treatments.^[5][12][14] contradicts

In their own wordsView sourceArchived copy

“Functional Medicine”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure IV Nutrient Therapy.

IV Nutrient Therapy

Supports

The influencer’s claim is very vague, but appears to imply that IV nutrient therapy is a generally appropriate and effective treatment that can be provided as part of chiropractic care. ^[4][7] High‑quality evidence supports IV nutrient therapy only in specific, medically supervised contexts, mainly as part of parenteral nutrition (PN) for patients unable to meet needs orally or enterally. Major clinical nutrition guidelines (ASPEN‑FELANPE and ESPEN) recommend intravenous or parenteral micronutrient provision as part of comprehensive nutrition support for hospitalized or critically ill patients, with careful assessment, monitoring, and prescription of micronutrients, not for general wellness or routine outpatient use. ^{[2][3][21][22][24]} Guidelines on when PN is appropriate emphasize that parenteral routes (including IV micronutrients) are reserved for defined indications such as intestinal failure, severe malabsorption, or situations where enteral feeding is not possible or adequate. ^[5] In these settings, IV micronutrients are typically ordered and monitored by physicians and nutrition support teams, consistent with guideline‑driven, evidence‑based care. ^[1] Some randomized controlled trials and meta‑analyses suggest potential benefits of specific IV vitamins in narrowly defined conditions. Meta‑analyses of intravenous vitamin C monotherapy in critically ill adults report a reduction in overall mortality compared with placebo or standard care in pooled analyses, although trial sequential analysis indicates that more high‑quality trials are needed. ^[23] Other meta‑analyses show that IV vitamin C may shorten ICU and hospital length of stay but have no clear effect on mortality or organ failure in critically ill patients. Small RCTs have explored IV vitamin C in settings such as fatigue in office workers, cardiac surgery, pneumonia, and septic shock protocols; some show modest short‑term benefits (e. g. , reduced fatigue, lower postoperative pulmonary complication scores), but these are small trials and not generalizable to broad wellness use. Overall, high‑quality evidence and guidelines support IV nutrient therapy as a specialized medical intervention (parenteral nutrition and adjunctive vitamin therapy) for appropriately selected patients under physician‑led care, not as a general wellness service, and they do not specifically endorse chiropractors as providers of IV nutrient therapy. ^[6]

Contradicts

The available high‑quality literature and guidelines do not support the broad, wellness‑oriented use of IV nutrient therapy commonly promoted by influencers, nor do they support chiropractors as typical providers of such therapy. ^[6][7][21] Clinical nutrition guidelines (ASPEN‑FELANPE, ESPEN) frame IV micronutrients within parenteral nutrition for patients with clear medical indications and under multidisciplinary, physician‑directed supervision; they do not recommend IV nutrient therapy for otherwise healthy individuals seeking energy, immune support, or general wellness. ^[2][3][24] Guidance on when parenteral nutrition is appropriate explicitly restricts its use to circumstances of impaired or contraindicated gastrointestinal function, not routine outpatient care. ^[5] Evidence for IV vitamin solutions in ambulatory or wellness contexts is weak. The only controlled trial of Myers’ cocktail (IV micronutrient therapy) for fibromyalgia found safety and feasibility but no significant differences in primary outcomes compared with placebo, with a strong placebo effect in both groups and uncertain efficacy. ^[22] A randomized trial of IV vitamin C in healthy office workers showed short‑term reduction in fatigue but was small, focused on a single outcome over 24 hours, and does not justify broad claims about overall health or chronic disease prevention. Systematic reviews and meta‑analyses of IV vitamin C in critically ill patients show mixed and often inconclusive results; some suggest possible mortality reduction, others show no mortality benefit, and trial sequential analysis consistently indicates insufficient evidence to recommend routine use. Large, high‑quality RCTs in serious illnesses sometimes show harm or no benefit from IV vitamin C. In adults with sepsis receiving vasopressor therapy, an international randomized trial found higher risk of death or persistent organ dysfunction in those receiving IV vitamin C versus placebo. ^[23] Harmonized RCTs in hospitalized COVID‑19 patients reported low probability of benefit and high posterior probability that IV vitamin C worsened organ support‑free days and survival, especially in critically ill patients. Trials combining high

In their own wordsView sourceArchived copy

“IV Nutrient Therapy”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Direct Primary Care.

Direct Primary Care

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Direct Primary Care Provider”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Weight gain.

Weight gain

Supports

High-quality evidence specifically showing that chiropractic spinal manipulation itself causes clinically meaningful weight loss or treats weight gain is essentially absent. Most available data on obesity and weight management involve lifestyle, pharmacologic, or surgical interventions rather than chiropractic care. A retrospective analysis of a weight-loss program delivered in a chiropractic clinic showed significant reductions in weight and BMI over 13 weeks, but this program relied on a multi‑modal regimen (dietary change, behavior modification, etc. ^[26][28] ), not spinal manipulation alone, and was uncontrolled and subject to bias; it therefore does not provide strong evidence that chiropractic treatment per se treats weight gain. Broader randomized trials across medicine show that structured lifestyle and behavioral interventions, interdisciplinary care, and digital or counseling-based programs can produce modest but significant weight loss, but these are not specific to chiropractic practices and are typically delivered by multidisciplinary or medical teams, not via manipulation alone. ^[25][27] High-quality guidelines and evidence reviews on hypertension, clinical nutrition, and parenteral nutrition emphasize diet, physical activity, pharmacotherapy, and in some cases surgery as primary tools for weight and cardiometabolic management, without recommending chiropractic manipulation as a weight-loss treatment. ^{[1][2][3][5][6]}

Contradicts

Existing medical literature on musculoskeletal procedures and spinal surgery indicates that relieving back pain or improving mobility does not reliably lead to weight loss, and in some cohorts overweight or obese patients are as likely to gain weight as to lose weight after spine interventions, undermining the idea that simply improving spinal function leads to spontaneous weight reduction. ^[25][27] Evidence on low back pain shows that obesity is associated with poorer outcomes across different types of care, suggesting that excess weight itself impairs response to musculoskeletal treatments, rather than being effectively treated by them. Systematic reviews, randomized trials, and major guidelines for obesity, hypertension, and clinical nutrition consistently focus on diet, physical activity, behavioral therapy, and drugs such as GLP‑1 receptor agonists as effective modalities for weight loss and risk reduction, and they do not identify chiropractic spinal manipulation as an evidence‑based treatment for weight gain. ^{[1][2][3][5][6][7][26][28]} High‑quality weight‑loss RCTs involving interdisciplinary programs, text‑message interventions, self‑weighing plus counseling, and diet‑based trials in diabetes and cancer populations demonstrate weight loss driven by these specific strategies, again without any role for chiropractic manipulation in producing the effect. Overall, the absence of randomized trials or meta‑analyses showing that chiropractic treatment alone induces weight loss, coupled with evidence that musculoskeletal procedures do not reliably change weight trajectories, contradicts the claim that chiropractic treatment is a proven therapy for weight gain. ^[4]

Mainstream view

The mainstream medical and scientific position is that weight gain and obesity are chronic, multifactorial conditions best managed through evidence‑based lifestyle interventions (nutritional counseling, caloric restriction, increased physical activity), behavioral therapies, approved pharmacologic agents such as GLP‑1 receptor agonists, and, in selected cases, bariatric surgery, guided by established clinical guidelines. ^{[1][2][6][25][27]} Clinical nutrition and obesity-related guidelines do not recommend chiropractic spinal manipulation as a primary or validated treatment for weight gain or obesity. ^{[3][5][26][28]} Chiropractic providers may participate in team-based care by offering general health counseling or implementing standard diet‑ and activity‑based programs, but when they do so, the effective components are the same lifestyle and behavioral strategies used across other medical settings, not the manual manipulation itself. Current high‑quality evidence and guidelines thus consider chiropractic treatment as a modality for musculoskeletal pain, not as a recognized or guideline‑endorsed intervention for weight gain. ^[4]

In their own wordsView sourceArchived copy

“battling weight gain”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Digestive symptoms.

Digestive symptoms

Supports

Evidence specific to chiropractic care for gastrointestinal or digestive symptoms is very limited and generally low quality. A narrative review of chiropractic treatment for gastrointestinal disorders identified only a couple of small, flawed clinical trials and concluded that there is no supportive evidence that chiropractic is an effective treatment for gastrointestinal disorders.^[6] Randomized trials and systematic reviews of manual therapies in general (including spinal manipulation) for reflux disease, duodenal ulcer, and other GI conditions show at best preliminary or equivocal benefits and classify the evidence as unclear or inconclusive, not definitive efficacy.^[1][3][5] Osteopathic manipulative treatment (OMT), a related but distinct manual therapy discipline, has somewhat more data in irritable bowel syndrome (IBS) and infant GI disorders; several small RCTs and meta-analyses suggest possible short‑term improvements in abdominal pain and constipation and some infant GI outcomes, but with low or very low certainty of evidence and methodological limitations.^{[4][8][11][12][14][15]} Major nutrition and gastroenterology guidelines for inflammatory bowel disease and enteral/parenteral nutrition focus on dietary, pharmacologic, and surgical management rather than chiropractic or spinal manipulation, implicitly reflecting that any contribution of chiropractic care is not established within guideline‑level evidence.^[2][3][4][5]

Contradicts

Systematic reviews specifically assessing chiropractic treatment for gastrointestinal problems report that there is no supportive evidence that chiropractic is an effective treatment for gastrointestinal disorders; existing trials are few, small, and methodologically weak.^[2][6] Broader evidence reports on spinal manipulation note that data do not convincingly demonstrate spinal manipulation to be an effective intervention for gastrointestinal conditions and rate the evidence as inconclusive or unclear.^[2][3] For IBS and other functional GI disorders, higher‑quality randomized trials and systematic reviews support evidence‑based treatments such as dietary modification, pharmacologic therapies, and psychological interventions, while manual spinal manipulation by chiropractors is not recommended as a standard treatment in mainstream guidelines.^[2][3][4][5] Clinical nutrition guidelines for inflammatory bowel disease and for indications for parenteral nutrition detail comprehensive evidence‑based strategies and do not include chiropractic treatment as a recommended therapy, underscoring the lack of recognized benefit.^[2][3][4][5] Overall, the best available evidence contradicts any strong claim that chiropractic treatment is an effective, established therapy for digestive symptoms across common GI disorders.

Mainstream view

Mainstream medical and scientific opinion is that chiropractic treatment is not an evidence‑based primary therapy for gastrointestinal or digestive disorders. Manual spinal manipulation may be used by chiropractors to address musculoskeletal complaints that coexist with GI symptoms, but gastroenterology and clinical nutrition guidelines emphasize pharmacologic management, dietary and lifestyle measures, psychological therapies, and, where appropriate, surgical and specialized nutrition support.^[2][3][4][5] Any potential benefit of chiropractic or spinal manipulation for GI symptoms is considered unproven and, at best, speculative based on small, low‑quality studies; major guidelines for inflammatory bowel disease, IBS, enteral and parenteral nutrition, and related conditions do not recommend chiropractic care as a standard intervention.^[2][3][4][5] In contrast, some related manual therapies such as osteopathic manipulative treatment have emerging but still low‑certainty evidence for modest symptom relief in IBS and certain infant GI conditions, and even these are regarded as adjunctive rather than core treatments.^{[4][8][11][12][14][15]} Therefore, the mainstream position is that patients with significant or persistent digestive symptoms should receive guideline‑directed medical evaluation and treatment, with chiropractic care, if used, confined to a complementary role and not relied upon as a primary treatment for GI disease.

In their own wordsView sourceArchived copy

“digestive symptoms”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise 6-month Metabolic Reset programs with GLP-1 oversight as within their scope of practice.

6-month Metabolic Reset programs with GLP-1 oversight

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“6-month Metabolic Reset programs with GLP-1 oversight”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Identifies root causes, not just symptoms as within their scope of practice.

Identifies root causes, not just symptoms

Supports

High-quality evidence supports chiropractic care as a noninvasive manual therapy that can reduce pain and improve function in certain musculoskeletal conditions (especially low back and neck pain), and guideline initiatives describe chiropractors as assessing and managing neuromusculoskeletal disorders rather than only suppressing pain symptoms.^{[9][10][14][22]} Clinical practice guidelines and professional scope-of-practice documents state that chiropractors evaluate patients, render a diagnosis, and develop a care plan for spine- and joint-related disorders, which is broader than pure symptomatic treatment and includes functional rehabilitation.^{[7][8][11][12][13]} Systematic reviews show spinal manipulation/manual therapy can be similarly effective to other recommended therapies for non-specific spine pain, sometimes with economic advantages and reduced downstream use of opioids, surgeries, and hospitalizations, which aligns with a more comprehensive management approach than isolated symptom relief.^{[2][4][18][22]}

Contradicts

The claim that chiropractic treatment broadly "identifies root causes" of disease is not supported by high-quality evidence: research and guidelines primarily evaluate chiropractic as a modality for musculoskeletal pain and function, not as a tool to uncover systemic or multifactorial root causes across medical conditions.^{[4][5][9][14]} Systematic reviews of manual therapy and chiropractic show low to moderate quality, inconsistent evidence and emphasize short-term pain and disability outcomes rather than validated identification and correction of underlying etiologic mechanisms.^[5][9][14] Mainstream medical guidelines for hypertension, parenteral nutrition, inflammatory bowel disease, tension-type headache, and blood transfusion describe pathophysiology, risk factors, and causal mechanisms in biomedical terms and do not include chiropractic care as an etiologic or disease-modifying intervention, indicating that "root cause" work-up for these conditions lies in evidence-based medical diagnostics and management instead.^{[0][1][2][3][4][6][7]} Professional chiropractic regulations describe scope of practice as assessing and treating neuromusculoskeletal conditions and dysfunctions, often with concepts like subluxation or somatic dysfunction that lack strong empirical support as true root causes of general health problems.^[7][11][13] Overall, current evidence supports chiropractic as one symptomatic and functional management option within musculoskeletal care, not as a general root-cause-identifying discipline across diseases.

Mainstream view

The mainstream medical and scientific view is that chiropractic is a conservative, nonpharmacologic manual therapy focused on assessment and treatment of neuromusculoskeletal conditions (spine, joints, related soft tissues), with evidence for benefit mainly in some low back and neck pain presentations and related musculoskeletal disorders.^{[4][9][10][14][22]} Standard evidence-based guidelines for major medical conditions (e.g., hypertension, inflammatory bowel disease, clinical nutrition decisions, pericarditis, tension-type headache, transfusion therapy) are built on pathophysiology, randomized trials, and systematic reviews and generally do not position chiropractic as a modality that identifies or corrects underlying disease causes; instead, chiropractors may contribute to pain management and functional improvement in appropriate musculoskeletal contexts.^{[0][1][2][3][4][5][7]} Within musculoskeletal care, best-practice chiropractic guidelines emphasize evidence-based assessment, diagnosis, multimodal management (manual therapy, exercise, education), and integration with broader healthcare rather than claims of uniquely uncovering root causes beyond the neuromusculoskeletal system.^{[9][12][15][16]}

In their own wordsView sourceArchived copy

“Identifies root causes, not just symptoms”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Personalized care plans based on advanced diagnostics as within their scope of practice.

Personalized care plans based on advanced diagnostics

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Personalized care plans based on advanced diagnostics”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Improved energy, metabolism, and cognitive function.

Improved energy, metabolism, and cognitive function

Supports

The generic claim that an intervention can improve energy, metabolism, and cognitive function is broadly consistent with multiple randomized controlled trials and lifestyle studies, but it is not specifically supported by the listed index trials, which are on unrelated topics such as miconazole resistance in infants, chemotherapy pharmacokinetics, swaddle bathing, and GI capsule endoscopy. ^[38][40] High‑quality evidence from RCTs and mechanistic trials outside this index list shows that certain interventions can improve cognition with concurrent changes in metabolic markers, for example aerobic exercise plus DASH diet, ketogenic MCT drinks, magnesium supplementation altering Ca:Mg ratios, and combined physical‑cognitive exercise with dietary changes; these collectively suggest that targeting metabolism and lifestyle can yield cognitive benefits and sometimes perceived energy improvements. ^[37][39] Several trials also demonstrate acute or short‑term improvements in perceived energy and cognitive performance with multi‑ingredient “energy” formulations or herbal extracts, indicating that increased subjective energy and task performance can be induced in the short term, although these are often modest and population‑specific.

Contradicts

The claim as stated is overly general and implies that improved energy, metabolism, and cognitive function are all reliably achieved by a single unspecified intervention, which is not supported by the index papers provided. ^[37][40] Many RCTs and mechanistic studies show mixed or limited effects: some metabolic interventions improve specific cognitive domains without clear effects on subjective energy; others change metabolic markers without measurable cognitive benefit; and in several trials, placebo groups improve similarly, indicating substantial expectation and practice effects. ^[38] Evidence linking general “energy” claims to meaningful changes in underlying metabolism or global cognition is often short‑term, based on subjective scales, and not replicated across diverse populations, so the overall evidentiary base for a broad, durable triad of improved energy, metabolism, and cognition remains weak. ^[39]

Mainstream view

Mainstream medical and scientific consensus is that certain targeted interventions—such as structured exercise programs, dietary modification, management of cardiometabolic risk factors, and treatment of specific deficiencies or diseases—can improve aspects of metabolism and some domains of cognitive function, and may enhance perceived energy, but effects are intervention‑specific, population‑specific, and usually modest rather than universal. ^[40] Major guidelines for cognitive health and metabolic disease emphasize long‑term lifestyle change, vascular and metabolic risk control, and evidence‑based pharmacologic or nutritional strategies, and they do not endorse broad influencer‑style promises that a single product or simple change will reliably improve energy, metabolism, and cognition for most people. ^[37][39] Clinicians typically view such global claims as marketing language rather than evidence‑based statements, and they expect proof from well‑designed RCTs with objective outcomes before accepting them as established.

In their own wordsView sourceArchived copy

“Improved energy, metabolism, and cognitive function”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Addresses long-term disease risk as within their scope of practice.

Addresses long-term disease risk

Supports

Several of the indexed papers are clinical guidelines or evidence-based reviews on standard therapies, and these clearly state that guideline-concordant treatment and appropriate nutrition support can reduce long-term disease risk or complications in specific conditions. ^[5][6][4] For example, evidence-based, guideline-driven management of hypertension is explicitly aimed at reducing long-term cardiovascular events such as myocardial infarction, stroke, and heart failure, thereby lowering long-term disease risk in hypertensive populations . ^[1] The ASPEN–FELANPE clinical nutrition guidelines emphasize that appropriate, individualized nutrition support in hospitalized and chronically ill patients reduces complications, infections, and mortality risk over time, which addresses long-term adverse outcomes related to malnutrition and disease progression . ^[2] The ESPEN guideline on clinical nutrition in inflammatory bowel disease highlights that optimizing nutritional status (including avoidance of severe malnutrition, micronutrient deficiencies, and sarcopenia) is part of comprehensive care that can improve disease course and long-term outcomes in IBD patients . ^[3] Guideline-based use of colchicine for recurrent pericarditis is supported by trials showing reductions in recurrence rates and symptom burden over extended follow-up, which addresses long-term risk of recurrent pericarditis episodes and associated morbidity . ^[8] Mainstream frameworks for evidence grading, such as GRADE, explicitly connect high-quality evidence and precise estimates of effect to more reliable conclusions about long-term benefit and risk, reinforcing that interventions supported by strong evidence are used to modify long-term disease risk rather than only short-term symptoms .

Contradicts

None of the cited index papers claim that a single, unspecified intervention universally addresses long-term disease risk across all diseases, nor that complex, multifactorial long-term risk can be fully controlled by a narrow or non–evidence-based strategy. Instead, they describe condition-specific, multifaceted management plans and stress that benefit for long-term outcomes depends on appropriate patient selection, dosing, adherence, and integration with other standard care . The ASPEN–FELANPE and ESPEN guidelines emphasize that nutrition support can both help and harm: inappropriate parenteral nutrition or misapplied feeding strategies may increase infection, metabolic complications, or mortality, so long-term risk can be worsened if evidence-based protocols are not followed . ^[2][3][5][6] Hypertension guidelines also underscore that untreated or inadequately managed blood pressure continues to confer high long-term risk for cardiovascular disease despite partial or intermittent treatment, contradicting any implication that minimal or non-guideline-concordant interventions fully address long-term risk . ^[4][7] Likewise, pericarditis evidence shows that colchicine reduces recurrences but does not eliminate long-term risk in all patients, and treatment must be individualized with attention to contraindications and comorbidities . ^[8] Overall, the indexed evidence contradicts any broad, unqualified claim that an unspecified influencer-endorsed approach, particularly if not guideline-based, reliably and comprehensively addresses long-term disease risk across conditions. ^[1]

Mainstream view

The mainstream medical position is that long-term disease risk is best addressed through comprehensive, evidence-based management tailored to specific conditions and patient factors, rather than through generic or unvalidated influencer-promoted strategies. ^[1] For hypertension, standard of care includes lifestyle modification plus guideline-directed pharmacologic therapy to reduce blood pressure and thereby lower long-term risk of cardiovascular events and mortality . ^[7] For patients with malnutrition or complex illness, expert guidelines such as ASPEN–FELANPE and ESPEN recommend individualized nutrition support (oral, enteral, or parenteral) guided by validated risk assessment tools, with clear indications, contraindications, and monitoring to improve long-term clinical outcomes while minimizing iatrogenic complications . ^[2][3][5] In inflammatory bowel disease, mainstream practice integrates optimized medical therapy (e. g. , immunomodulators, biologics) with targeted nutrition interventions to reduce flares, hospitalizations, surgery, and long-term disability risk rather than relying on nutrition alone . For recurrent pericarditis, colchicine and anti-inflammatory drugs are used according to trial data and guideline recommendations to reduce recurrence risk, but clinicians recognize that long-term outcomes depend on etiology, comorbidities, and treatment adherence . ^[4][8] Across these areas, mainstream guidance relies on structured evidence appraisal systems such as GRADE, which stress that long-term risk modification claims must be grounded in high-quality evidence, precise estimates of effect, and transparent reporting of uncertainty . ^[6]

In their own wordsView sourceArchived copy

“Addresses long-term disease risk”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Learn More about Functional Medicine as within their scope of practice.

Learn More about Functional Medicine

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Learn More about Functional Medicine”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Advanced cardiovascular and metabolic screening.

Advanced cardiovascular and metabolic screening

Supports

There is limited indirect support that chiropractors, especially those practicing in sports or primary-care–like roles, may perform some basic cardiovascular risk assessment and order laboratory tests relevant to metabolic risk. One sports chiropractic study reports that chiropractic sports physicians commonly order tests such as comprehensive metabolic panels, fasting glucose, hemoglobin A1c, and lipid panels, which are components of metabolic and cardiovascular risk screening^[11]. Chiropractors involved in pre‑participation examinations are advised to take histories that include hypertension, heart disease, and cardiovascular symptoms and to follow American Heart Association pre‑participation cardiovascular screening recommendations, referring positives to appropriate medical specialists^[1]. These activities amount to basic, questionnaire‑based cardiovascular risk screening rather than advanced diagnostic work.

Contradicts

None of the indexed high‑quality guidelines provided (hypertension management, nutrition guidelines, transfusion therapy, headache treatment, evidence-rating methodology) support chiropractors as providers of advanced cardiovascular or metabolic diagnostic screening; instead, they describe medical management pathways that assume physician-led evaluation and testing^{[0][1][2][3][4][6][7]}. Major cardiovascular prevention and screening guidelines generally position physicians and established medical specialists (cardiologists, internists, family physicians) as the responsible clinicians for guideline‑driven cardiovascular and metabolic screening and interpretation, not chiropractors, and studies of compliance with lipid and glucose screening in rheumatoid arthritis populations show that family physicians ordered nearly all tests^[20][22]. The typical chiropractic scope-of-practice documents and standards emphasize assessment and treatment of spine, joints, and neuromusculoskeletal conditions, not advanced cardiovascular or metabolic diagnostics, and where chiropractors screen for risk they are expected to refer abnormal findings to medical providers rather than manage them independently^[13][14]. Overall, there is no evidence from randomized trials, systematic reviews, or major cardiometabolic guidelines that chiropractic training or scope supports “advanced” cardiovascular and metabolic screening comparable to that conducted in mainstream medical practice.

Mainstream view

Mainstream medical and scientific consensus is that advanced cardiovascular and metabolic screening—such as guideline‑directed workups for hypertension, diabetes, dyslipidemia, heart failure, or atrial fibrillation—is designed, overseen, and interpreted by physicians and other medically trained professionals following cardiology, endocrinology, and primary care guidelines^{[0][18][19][20][22]}. Chiropractors may play a limited role in basic risk assessment, lifestyle counseling, and ordering standard laboratory panels in some jurisdictions, but are not considered primary providers of advanced cardiovascular or metabolic diagnostics, and abnormal findings should be triaged to appropriate medical specialists. Evidence-based frameworks like GRADE emphasize that high‑stakes cardiovascular and metabolic decisions require high‑quality, precise evidence and specialist interpretation, which current literature does not attribute to chiropractic practice^[5].

In their own wordsView sourceArchived copy

“Advanced cardiovascular and metabolic screening”

Rule: K.S.A. 65-2871(a)

See every doc bro who says they can treat or advise on Heart disease and cholesterol

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Improved energy, resilience, and body composition.

Improved energy, resilience, and body composition

Supports

The influencer’s claim is broad (“improved energy, resilience, and body composition”) and not linked to a specific intervention, but several high‑quality trials and reviews show that structured diet and exercise programs can improve body composition and physical function, which is often experienced as better “energy” and resilience in daily activities. A large systematic review and meta-analysis on combined diet and exercise in adults found that integrated interventions consistently improved body mass index, body fat percentage, and total body water compared with control, with supervised programs of ≥12 weeks being most effective; these changes in body composition and functional capacity can reasonably be interpreted as improved physical energy for activities.^[18] Randomized trials of weight‑loss and body‑composition interventions (e.g., very low carbohydrate diets, yacon flour plus energy restriction, high‑protein nutrient‑dense supplements combined with exercise) show reductions in fat mass, preservation or increases in lean mass, improved aerobic capacity, and better physical performance, all consistent with better body composition and functional “energy.”^[18] A meta-analysis of resilience interventions (CBT-based, mindfulness, and mixed approaches) reported a moderate positive effect size (~0.44) on psychological resilience, indicating that targeted behavioral programs can meaningfully improve resilience as an outcome.^[5][15]

Contradicts

Because the claim is generic and untied to any specific product, supplement, or protocol, there is no direct high‑quality evidence that “any given influencer intervention” will reliably improve energy, resilience, and body composition. Many body‑composition RCTs show benefits only under tightly controlled conditions (e.g., supervised exercise plus defined diet, or specific macronutrient patterns); such effects may not generalize to loosely defined or short-term influencer programs.^[18] Large randomized trials of single supplements (for example, vitamin D3 in generally healthy older adults) have found no meaningful improvements in weight or body composition overall, illustrating that not all popular interventions change body composition or perceived energy.^[23] Some interventions improve metabolic markers or glucose control without measurable changes in body composition or physical function, underscoring that improved lab values do not automatically translate into better energy or resilience.^[21] Psychological resilience interventions show only moderate effects and are often context‑specific (e.g., workplace stress, clinical populations), so they do not support broad claims that any general lifestyle program will substantially increase resilience in all users.^[5][15]

Mainstream view

Mainstream medical and scientific consensus is that improvements in body composition and physical energy are most reliably achieved through evidence‑based combinations of regular physical activity (especially resistance and mixed exercise) and appropriate dietary energy restriction or macronutrient adjustment, often under supervision.^[12][18] Major systematic reviews and guidelines emphasize that combined diet‑plus‑exercise interventions over at least several weeks can reduce fat mass, preserve or increase lean mass, and enhance physical function, but results depend on adherence, program intensity, and individual health status.^[12][18] Psychological resilience is viewed as modifiable but not easily changed; structured CBT‑based, mindfulness, and multicomponent programs can produce modest to moderate improvements, whereas generic, non‑specific “resilience” content has much weaker evidentiary support.^[5][15] Overall, the mainstream position is that meaningful improvements in energy, resilience, and body composition are possible, but require well‑designed, sustained interventions; broad, unqualified influencer claims that unspecified methods will reliably deliver all three outcomes are not supported by high‑quality evidence.

In their own wordsView sourceArchived copy

“Improved energy, resilience, and body composition”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Cognitive and physical performance support as within their scope of practice.

Cognitive and physical performance support

Supports

The influencer’s claim is extremely vague (“Cognitive and physical performance support”) and does not specify any particular intervention, dose, or population, so it cannot be directly matched to the listed index trials, which concern unrelated topics such as antifungal resistance in infants, chemotherapy pharmacokinetics, thyroid surgery complications, and musculoskeletal pain protocols. ^[52] Outside these index papers, there is high-quality evidence that certain structured interventions can improve aspects of cognitive and physical performance: randomized controlled trials (RCTs) of combined physical and cognitive training in healthy adults show improvements in executive function, reaction time, and physical performance measures compared with physical training alone or separate training, supporting the general idea that interventions can simultaneously benefit cognition and physical performance. ^[50][51] RCTs of exercise programs (aerobic, resistance, and complex motor training) demonstrate improved cardiorespiratory fitness, strength, and selected cognitive domains (e. g. , executive function, processing speed), particularly in older adults and, to a lesser extent, in younger adults. Systematic reviews and meta-analyses on ergogenic supplements in trained athletes indicate that specific supplements (e. g. , creatine for strength, protein for endurance, caffeine for power/output) can meaningfully enhance physical performance, and some acute multi-ingredient “nootropic” or energy formulations plus caffeine have shown short-term improvements in attention, working memory, and task accuracy in healthy adults. Overall, high-quality evidence supports that targeted, well-defined interventions (structured exercise, cognitive training, and some evidence-based supplements like caffeine or creatine) can confer measurable cognitive and physical performance benefits, but this support is specific to clearly described interventions rather than an unspecified influencer claim.

Contradicts

None of the eight index trials provided (miconazole resistance, nab-paclitaxel plus gemcitabine, metformin for autophagy, swaddle bathing, remote GI capsule endoscopy, thyroid surgery nerve risk factors, text-neck therapies, and camlipixant pharmacology) investigate general “cognitive and physical performance support,” so they neither support nor validate the influencer’s broad performance claim. ^[52] High-quality evidence reviewing cognitive effects of exercise in healthy populations has highlighted important limitations: umbrella reviews of RCTs show that apparent cognitive benefits of physical exercise are small and often become negligible after correcting for biases (publication bias, low power, and analytic flexibility), arguing that strong, generalized claims about large cognitive improvements in all healthy people from “performance support” interventions are overstated. ^[50] Many RCTs of supplements commonly marketed for performance show either minimal or domain-specific effects, or no improvement in global cognition or broad physical performance, especially in already healthy, non-deficient populations (e. g. , vitamin D supplementation often fails to improve physical performance despite correcting deficiency; protein supplementation beyond adequate intake has limited incremental effects on performance in some athletes). ^[53] Acute “nootropic” or functional beverage trials frequently show short-term task-specific gains (e. g. , reaction time under test conditions), not broad, sustained enhancement of everyday cognitive or physical functioning. Thus, while certain interventions can yield statistically significant improvements in narrowly defined outcomes, the evidence contradicts simplistic influencer narratives that generic products or vague “support” regimens reliably and substantially boost overall cognitive and physical performance in all users.

Mainstream view

Mainstream medical and scientific views distinguish between specific, evidence-based interventions and generic marketing claims. Large bodies of RCTs and systematic reviews support that structured aerobic and resistance exercise, often combined with skillful motor or cognitive training, improves physical performance (strength, endurance, power, cardiorespiratory fitness) and can confer modest gains in selected cognitive domains (especially executive functions and processing speed in older adults). Evidence-based ergogenic aids such as caffeine and creatine are accepted in sports medicine as having reproducible benefits for certain physical performance outcomes, and some acute multi-ingredient nootropic or energy formulations can transiently improve specific cognitive test scores under laboratory conditions. However, mainstream experts emphasize that cognitive improvements from exercise in healthy adults are typically small, heterogeneous, and sensitive to bias, and that most supplement trials show limited or domain-specific benefits rather than global, long-term enhancement. ^[50] Therefore, the mainstream position is that “cognitive and physical performance” can be supported in targeted ways by clearly defined interventions (regular exercise, sleep optimization, addressing nutrient deficiencies, selective use of well-studied ergogenic aids), but broad influencer claims that ^[52]

In their own wordsView sourceArchived copy

“Cognitive and physical performance support”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Reduced long-term chronic disease risk as within their scope of practice.

Reduced long-term chronic disease risk

Supports

The influencer’s very broad claim that some intervention “reduces long-term chronic disease risk” is partly aligned with high-quality evidence showing that certain established interventions do reduce future chronic disease events, especially cardiovascular disease and type 2 diabetes, but none of the indexed trials you provided directly test a generalized anti-aging or global chronic disease risk reduction outcome. Large systematic reviews and network meta-analyses of randomized controlled trials find that blood-pressure–lowering medications, tight blood pressure control, statins used appropriately, and multifactorial lifestyle interventions significantly reduce composite cardiovascular events and all-cause mortality in primary prevention, which are major chronic diseases. ^[55] Systematic reviews of dietary interventions and randomized dietary trials indicate that healthy dietary patterns produce modest but real reductions in incident cardiovascular disease and type 2 diabetes over several years, supporting diet as a chronic disease risk–reducing strategy. A broad primary prevention review of chronic noncommunicable diseases reports that health promotion and primary prevention strategies (e. g. , tobacco control, diet, physical activity) are central to reducing chronic disease burden, reinforcing that well-established lifestyle and pharmacologic measures can reduce long-term risk. Tai Chi and similar physical activity patterns have been associated in systematic reviews with lower stroke incidence or improvements in stroke risk factors in middle-aged and older adults, again consistent with the idea that long-term structured physical activity can lower risk of some chronic vascular diseases. Regarding metformin, mechanistic and clinical reviews describe it as a potential geroprotective drug, attenuating hallmarks of aging (nutrient sensing, autophagy, inflammation) and lowering risk of several age-related conditions such as cardiometabolic disorders, some cancers, and frailty, though the evidence is strongest for diabetes and cardiovascular risk rather than broad chronic disease prevention in healthy people. ^[54] The indexed metformin trial in adults with prediabetes is designed to test anti-aging, pro-autophagy effects and surrogate markers of inflammation and aging, which are biologically relevant to chronic disease risk, but it is a feasibility study focused on short-term markers rather than long-term hard clinical endpoints. ^[46]

Contradicts

The claim as stated is extremely general and suggests a broad reduction in long-term chronic disease risk, but the indexed trials are heterogeneous and do not collectively support a single intervention that clearly and robustly reduces overall chronic disease risk; several are purely pharmacokinetic, safety, or feasibility studies with no chronic disease outcomes. The camlipixant hepatic impairment study is a phase 1 pharmacokinetics and safety trial and does not evaluate chronic disease risk or prevention, so it cannot be taken as evidence that this drug reduces long-term chronic disease risk. The metformin pro-autophagy trial in prediabetes assesses surrogate biomarkers of cellular senescence and autophagy, not long-term clinical outcomes like incident cardiovascular events, diabetes progression over many years, cancer, or mortality; using such pilot biomarker data as proof of reduced long-term chronic disease risk oversteps the evidence base. ^[46][54] Geroscience reviews on metformin emphasize promising mechanisms and observational or secondary outcome data, but they consistently note that definitive randomized trials with chronic disease endpoints in general populations (such as TAME-type trials) are still ongoing and that evidence for broad anti-aging or pan–chronic disease prevention remains incomplete. A systematic review of antileukotrienes in very preterm infants, for example, finds no evidence that montelukast prevents chronic lung disease or improves mortality or long-term outcomes and concludes that prevention of chronic lung disease with this approach is not supported by available evidence; this illustrates that not all mechanistically plausible interventions successfully reduce chronic disease risk when tested rigorously. Consultation-based adherence interventions for primary or secondary prevention medications show only modest improvements in adherence and no robust, consistent improvements in clinical outcomes such as blood pressure, LDL cholesterol, HbA1c, or hospitalizations, highlighting that even plausible behavioral strategies may fail to produce strong long-term chronic disease risk reductions in trials. ^[55] Some chronic disease prevention programs implemented in

In their own wordsView sourceArchived copy

“Reduced long-term chronic disease risk”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Learn More about Longeivty Medicine as within their scope of practice.

Learn More about Longeivty Medicine

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Learn More about Longeivty Medicine”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Improved energy and mental clarity.

Improved energy and mental clarity

Supports

High-quality evidence can support improved energy and mental clarity in specific contexts, not as a universal effect. ^[6] A randomized, double-blind placebo-controlled study of a botanical blend reported increased alertness and improved cognitive performance, with attention effects most robust. A qualitative analysis nested within a double-blind randomized trial of ashwagandha reported perceived sustained energy and heightened mental clarity over 30 days. ^[57] Systematic reviews on fatigue and cognition show that treating underlying fatigue states can improve functioning, and guideline-based care for some conditions includes managing fatigue and cognitive symptoms, but these benefits are condition-specific rather than general claims. ^{[1][56][58][59]}

Contradicts

The claim is too broad for the evidence base. Systematic reviews of fatigue management find that much of the guideline evidence is low quality and that only a minority of clinical guidelines even address fatigue management. ^{[1][2][3][6][4][56][57][58][59]} Reviews of fatigue and cognition also report insufficient evidence in several chronic illness populations, and no high-quality evidence shows that a generic product or intervention reliably improves energy and mental clarity in healthy people. The index papers are mostly condition-specific nutrition or symptom-management guidelines and do not establish a general nootropic or energy-boosting effect. ^[5]

Mainstream view

Mainstream medical and scientific opinion is that improved energy and mental clarity are plausible short-term outcomes only in selected settings, such as correcting deficiencies, treating fatigue-related illness, sleep loss, or using certain interventions with limited condition-specific evidence. ^{[56][57][58][59]} For the average healthy person, evidence is inconsistent or weak, so a general claim of improved energy and mental clarity is not well supported. ^[6] Evidence-based guidelines emphasize identifying underlying causes of fatigue and using targeted treatment rather than assuming broad cognitive-energy enhancement. ^[1][2]

In their own wordsView sourceArchived copy

“Improved energy and mental clarity”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Better sleep and mood stability as within their scope of practice.

Better sleep and mood stability

Supports

The indexed guidelines on hypertension, clinical nutrition, parenteral nutrition, tension-type headache, blood transfusion, and colchicine do not directly evaluate sleep quality or mood stability as primary outcomes, so they cannot be cited as high-quality evidence that these interventions generally produce better sleep or mood. ^{[1][2][3][5][6][7][8][60][61][63]} However, the EFNS guideline on tension-type headache notes the effectiveness of amitriptyline and other antidepressants for chronic tension-type headache, and such agents are known from broader psychiatric literature to improve depressive symptoms, which may secondarily stabilize mood in appropriately selected patients. ^[4] The EFNS guideline also recommends cognitive-behavioural therapy and relaxation training, which are supported by broader headache literature as improving headache-related dysfunction and often sleep quality when integrated with sleep-focused CBT, though the guideline itself does not quantify sleep or mood endpoints. Narrative and guideline-type sources on tension-type headache and nonpharmacologic management emphasize stress reduction and sleep hygiene to improve headache-related quality of life, implicitly linking optimized sleep with better overall functioning, which can include mood stability, but this is inferential rather than formally tested in RCTs within the indexed set. ^[62]

Contradicts

Guideline-driven hypertension management, parenteral nutrition appropriateness criteria, ASPEN-FELANPE and ESPEN nutrition guidelines, blood transfusion therapy reviews, and colchicine in pericarditis papers focus on mortality, morbidity, disease-specific outcomes, and safety; they do not claim or demonstrate that these interventions routinely improve sleep or mood stability, so using them to justify such a claim extends beyond the evidence. ^{[1][2][3][5][6][7][8]} Parenteral nutrition guidelines emphasise indications, metabolic complications, and monitoring, and they also acknowledge burden and risks; they do not present data that PN improves sleep or mood and, in practice, PN can be associated with sleep disruption and psychological distress rather than improvement. ^[61] The EFNS tension-type headache guideline specifically states that non-drug management has a limited scientific basis and that evidence for physical therapies and some behavioural approaches is not robust, indicating that any expectation of consistent improvement in sleep or mood from these strategies alone is not strongly supported. ^{[4][60][62][63]} Overall, none of the indexed high-quality sources provide direct, controlled evidence that the treatments they discuss reliably produce "better sleep and mood stability" as general outcomes, and some highlight the complexity of these conditions and the limited evidence base for psychosocial and lifestyle interventions.

Mainstream view

Mainstream medical and scientific positions recognise that adequate control of chronic disease, pain, and nutritional deficits can indirectly improve aspects of sleep and mood, but major guidelines on hypertension, clinical and parenteral nutrition, blood transfusion, and pericarditis do not frame these therapies primarily as tools to enhance sleep quality or mood stability. ^{[2][3][5][6][7][8][61]} In headache medicine, authoritative guidelines such as the EFNS tension-type headache guideline acknowledge that cognitive-behavioural therapies, relaxation, biofeedback, and prophylactic antidepressants (e. ^[4][60][63] g. , amitriptyline) can reduce headache burden and, in broader literature, are associated with improved mood and sometimes sleep, but they emphasise that the evidence base for non-drug interventions is limited and that treatment should be individualised rather than promising global improvements in sleep and mood for all patients. ^[62] Mainstream practice therefore views better sleep and mood stability as possible but not guaranteed secondary benefits of appropriately targeted disease management and psychosocial interventions, not as universal outcomes of the specific guideline-driven treatments covered in the indexed papers. ^[1]

In their own wordsView sourceArchived copy

“Better sleep and mood stability”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Enhanced metabolic and sexual health as within their scope of practice.

Enhanced metabolic and sexual health

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Enhanced metabolic and sexual health”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Personalized and medically supervised care as within their scope of practice.

Personalized and medically supervised care

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Personalized and medically supervised care”

Rule: K.S.A. 65-2871(a)

Tanner Wilson is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Learn More about BHRT as within their scope of practice.

Learn More about BHRT

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Learn More about BHRT”

Rule: K.S.A. 65-2871(a)